MRRS adds "70 kDa Ribosomal Protein S6 Kinase (p70S6K or EC 2.7.11.1) – Pipeline Review, H2 2016" latest studies, published in December 2016. It is a professional and in-depth study.

Summary
Global Markets Direct’s, ‘70 kDa Ribosomal Protein S6 Kinase (p70S6K or EC 2.7.11.1) – Pipeline Review, H2 2016’, provides in depth analysis on 70 kDa Ribosomal Protein S6 Kinase (p70S6K or EC 2.7.11.1) targeted pipeline therapeutics.

The report provides comprehensive information on the 70 kDa Ribosomal Protein S6 Kinase (p70S6K or EC 2.7.11.1) , targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in 70 kDa Ribosomal Protein S6 Kinase (p70S6K or EC 2.7.11.1) targeted therapeutics development and features dormant and discontinued projects.

Table Of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
70 kDa Ribosomal Protein S6 Kinase (p70S6K or EC 2.7.11.1) Overview 6
Therapeutics Development 7
70 kDa Ribosomal Protein S6 Kinase (p70S6K or EC 2.7.11.1) - Products under Development by Stage of Development 7
70 kDa Ribosomal Protein S6 Kinase (p70S6K or EC 2.7.11.1) - Products under Development by Therapy Area 8
70 kDa Ribosomal Protein S6 Kinase (p70S6K or EC 2.7.11.1) - Products under Development by Indication 9
70 kDa Ribosomal Protein S6 Kinase (p70S6K or EC 2.7.11.1) - Pipeline Products Glance 10
Late Stage Products 10
Early Stage Products 11
70 kDa Ribosomal Protein S6 Kinase (p70S6K or EC 2.7.11.1) - Products under Development by Companies 12
70 kDa Ribosomal Protein S6 Kinase (p70S6K or EC 2.7.11.1) - Therapeutics Assessment 14
Assessment by Monotherapy/Combination Products 14
Assessment by Mechanism of Action 15
Assessment by Route of Administration 16
Assessment by Molecule Type 17
70 kDa Ribosomal Protein S6 Kinase (p70S6K or EC 2.7.11.1) - Companies Involved in Therapeutics Development 18
ArQule, Inc. 18
Astex Pharmaceuticals Inc 19
Eddingpharm 20
Merck KGaA 21
PharmAust Limited 22
Phoenix Biotechnology, Inc. 23
Sentinel Oncology Limited 24
70 kDa Ribosomal Protein S6 Kinase (p70S6K or EC 2.7.11.1) - Drug Profiles 25
AT-13148 - Drug Profile 25
Product Description 25
Mechanism Of Action 25
R&D Progress 25
EDP-317 - Drug Profile 27
Product Description 27
Mechanism Of Action 27
R&D Progress 27
M-2698 - Drug Profile 28
Product Description 28
...

Browse Complete Report with TOC @
http://www.marketresearchreportstore.com/shop/70-kda-ribosomal-protein-s6-kinase-p70s6k-or-ec-2-7-11-1-pipeline-review-h2-2016

Ask a sample and any further questions, please feel free to contact us:
Tel: +00-1-626-3463946 - U.S
Email: [email protected]
Web: http://www.marketresearchreportstore.com/

About Market Research Report Store
Since the establishment, Market Research Report Store has determined to take the online market research reports platform to the next level. With our passion and profession, we are designed to be the best among the bests.
Market Research Report Store is one of the most fast-growing and professional online platforms for industry reports, market reports, and professional surveys. Our collection covers more than 100 global markets. We have cooperated with leading publishers and consultant companies to offer the best market intelligence products to our clients with instant access to our database.